IBDEI0YH ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15360,0)
 ;;=K51.311^^85^846^22
 ;;^UTILITY(U,$J,358.3,15360,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15360,1,3,0)
 ;;=3^Ulcerative Rectosigmoiditis w/ Bleeding
 ;;^UTILITY(U,$J,358.3,15360,1,4,0)
 ;;=4^K51.311
 ;;^UTILITY(U,$J,358.3,15360,2)
 ;;=^5008667
 ;;^UTILITY(U,$J,358.3,15361,0)
 ;;=K51.318^^85^846^23
 ;;^UTILITY(U,$J,358.3,15361,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15361,1,3,0)
 ;;=3^Ulcerative Rectosigmoiditis w/ Other complication
 ;;^UTILITY(U,$J,358.3,15361,1,4,0)
 ;;=4^K51.318
 ;;^UTILITY(U,$J,358.3,15361,2)
 ;;=^5008671
 ;;^UTILITY(U,$J,358.3,15362,0)
 ;;=K51.30^^85^846^24
 ;;^UTILITY(U,$J,358.3,15362,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15362,1,3,0)
 ;;=3^Ulcerative Rectosigmoiditis,Uncomplicated
 ;;^UTILITY(U,$J,358.3,15362,1,4,0)
 ;;=4^K51.30
 ;;^UTILITY(U,$J,358.3,15362,2)
 ;;=^5008666
 ;;^UTILITY(U,$J,358.3,15363,0)
 ;;=K51.211^^85^846^25
 ;;^UTILITY(U,$J,358.3,15363,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15363,1,3,0)
 ;;=3^Ulcerative Proctitis w/ Bleeding
 ;;^UTILITY(U,$J,358.3,15363,1,4,0)
 ;;=4^K51.211
 ;;^UTILITY(U,$J,358.3,15363,2)
 ;;=^5008660
 ;;^UTILITY(U,$J,358.3,15364,0)
 ;;=K51.218^^85^846^26
 ;;^UTILITY(U,$J,358.3,15364,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15364,1,3,0)
 ;;=3^Ulcerative Proctitis w/ Other complication
 ;;^UTILITY(U,$J,358.3,15364,1,4,0)
 ;;=4^K51.218
 ;;^UTILITY(U,$J,358.3,15364,2)
 ;;=^5008664
 ;;^UTILITY(U,$J,358.3,15365,0)
 ;;=K51.20^^85^846^27
 ;;^UTILITY(U,$J,358.3,15365,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15365,1,3,0)
 ;;=3^Ulcerative Proctitis,Uncomplicated
 ;;^UTILITY(U,$J,358.3,15365,1,4,0)
 ;;=4^K51.20
 ;;^UTILITY(U,$J,358.3,15365,2)
 ;;=^5008659
 ;;^UTILITY(U,$J,358.3,15366,0)
 ;;=K51.811^^85^846^28
 ;;^UTILITY(U,$J,358.3,15366,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15366,1,3,0)
 ;;=3^Ulcerative Colitis,Other w/ Bleeding
 ;;^UTILITY(U,$J,358.3,15366,1,4,0)
 ;;=4^K51.811
 ;;^UTILITY(U,$J,358.3,15366,2)
 ;;=^5008688
 ;;^UTILITY(U,$J,358.3,15367,0)
 ;;=K51.818^^85^846^29
 ;;^UTILITY(U,$J,358.3,15367,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15367,1,3,0)
 ;;=3^Ulcerative Colitis,Other w/ Other complication
 ;;^UTILITY(U,$J,358.3,15367,1,4,0)
 ;;=4^K51.818
 ;;^UTILITY(U,$J,358.3,15367,2)
 ;;=^5008692
 ;;^UTILITY(U,$J,358.3,15368,0)
 ;;=K51.80^^85^846^30
 ;;^UTILITY(U,$J,358.3,15368,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15368,1,3,0)
 ;;=3^Ulcerative Colitis,Other,Uncomplicated
 ;;^UTILITY(U,$J,358.3,15368,1,4,0)
 ;;=4^K51.80
 ;;^UTILITY(U,$J,358.3,15368,2)
 ;;=^5008687
 ;;^UTILITY(U,$J,358.3,15369,0)
 ;;=B25.8^^85^846^31
 ;;^UTILITY(U,$J,358.3,15369,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15369,1,3,0)
 ;;=3^Cytomegaloviral colitis
 ;;^UTILITY(U,$J,358.3,15369,1,4,0)
 ;;=4^B25.8
 ;;^UTILITY(U,$J,358.3,15369,2)
 ;;=^5000559
 ;;^UTILITY(U,$J,358.3,15370,0)
 ;;=M07.69^^85^846^32
 ;;^UTILITY(U,$J,358.3,15370,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15370,1,3,0)
 ;;=3^Enteropathic arthropathies,Multiple sites
 ;;^UTILITY(U,$J,358.3,15370,1,4,0)
 ;;=4^M07.69
 ;;^UTILITY(U,$J,358.3,15370,2)
 ;;=^5010169
 ;;^UTILITY(U,$J,358.3,15371,0)
 ;;=M07.68^^85^846^33
 ;;^UTILITY(U,$J,358.3,15371,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15371,1,3,0)
 ;;=3^Enteropathic arthropathies,Vertebrae
 ;;^UTILITY(U,$J,358.3,15371,1,4,0)
 ;;=4^M07.68
 ;;^UTILITY(U,$J,358.3,15371,2)
 ;;=^5010168
